Ethyl pyruvate: A novel treatment for sepsis

Novartis Foundation Symposium

Volumn 280, Issue , 2007, Pages 147-156

  Fink, Mitchell P ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PYRUVIC ACID DERIVATIVE; PYRUVIC ACID ETHYL ESTER; UNCLASSIFIED DRUG;

ANIMAL; HUMAN; PATHOPHYSIOLOGY; REVIEW; SEPSIS;

ANIMALS; HUMANS; PYRUVATES; SEPSIS;

EID: 34247148911     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (40)

1. Bowie AG, Moynagh PN, O'Neill LAJ 1997 Lipid peroxidation is involved in the activation of NF-kB by tumor necrosis factor but not interleukin-1 in the human endothelial cell line ECV304. J Biol Chem 272:25941-25950
2. Bunger R, Mallet RT, Hartman DA 1989 Pyruvate-enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart. Near-complete prevention of reperfusion contractile failure. Eur J Biochem 180:221-233
3. Chandel NS, Trzyna WC, McClintock DS, Schumacker PT 2000 Role of oxidants in NF-kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin. J Immunol 165:1013-1021
4. Cicalese L, Lee K, Schraut W, Watkins S, Borle A, Stanko R 1999 Pyruvate prevents ischemia-reperfusion mucosal injury of rat small intestine. Am J Surg 171:97-100
5. Dear JW, Kobayashi H, Jo SK et al 2005 Dendrimer-enhanced MRI as a diagnostic and prognostic biomarker of sepsis-induced acute renal failure in aged mice. Kidney Int 67:2159-2167
6. Dobsak P, Courdertot-Masuyer C, Zeller M et al 1999 Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia. J Cardiovasc Pharmacol 34:651-659
7. Dupuis G, Mitchell JC, Towers GH 1974 Reaction of alantolactone, an allergenic sesquiterpene lactone, with some amino acids. Resultant loss of immunologic reactivity. Can J Biochem 52:575-581
8. Fink MP, Heard SO 1990 Research review: laboratory models of sepsis and septic shock. J Surg Res 49:186-196
9. Garcia-Pineres AJ, Castro V, Mora G et al 2001 Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones. J Biol Chem 276:39713-39720
10. Han Y, Englert JA, Yang R, Delude RL, Fink MP 2005 Ethyl pyruvate inhibits NF-{kappa} B-dependent signaling by directly targeting p65. J Pharmacol Exp Ther 312:1097-1115
11. Hauser B, Kick J, Asfar P et al 2005 Ethyl pyruvate improves systemic and hepato-splanchnic hemodynamics and prevents lipid peroxidation in a porcine model of resuscitated hyperdynamic endotoxemia. Crit Care Med 33:2034-2042
12. Hay AJB, Hamburger M, Hostettmann K, Hoult JRS 1994 Toxic inhibition of smooth muscle contractility by plant-derived sesquiterpenes caused by their chemically reactive alpha-methylenebutyrolactone functions. Br J Pharmacol 112:9-12
13. Holleman MAF 1904 Notice sur l'action de l'eau oxygénée sur les acétoniques et sur le dicétones 1.2. Recl Trav Chim Pays-bas Belg 23:169-171
14. Kim JB, Yu YM, Kim SW, Lee JK 2005 Anti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious neuroprotection in the postischemic brain. Brain Res 1060:188-192
15. Klenzak J, Himmelfarb J 2005 Sepsis and the kidney. Crit Care Clin 21:211-222
16. Lyss G, Knorre A, Schmidt TJ, Pahl HL, Merfort I 1998 The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65. J Biol Chem 273:33508-33516
17. Miyaji T, Hu X, Yuen PST et al 2003 Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice. Kidney Int 64:1620-1631
18. Montgomery CM, Webb JL 1956 Metabolic studies on heart mitochondria. II. The inhibitory action of parapyruvate on the tricarboxylic acid cycle. J Biol Chem 221:359-368
19. Parikh AA, Moon MR, Pritts TA et al 2000 IL-1beta induction of NF-kappaB activation in human intestinal epithelial cells is independent of oxyradical signaling. Shock 13:8-13
20. Salahudeen AK, Clark EC, Nath KA 1991 Hydrogen peroxide-induced renal injury. A protective role for pyruvate in vitro and in vivo. J Clin Invest 88:1886-1893
21. Salzman AL, Denenberg AG, Ueta I, O'Connor M, Linn SC, Szabo C 1996 Induction and activity of nitric oxide synthase in cultured human intestinal epithelial monolayers. Am J Physiol 270:G565-573
22. Sappington PL, Fink ME, Yang R, Delude RL, Fink MP 2003a Ethyl pyruvate provides durable protection against inflammation-induced intestinal epithelial barrier dysfunction. Shock 20:521-528
23. Sappington PL, Han X, Yang R, Delude RL, Fink MP 2003b Ethyl pyruvate ameliorates intestinal epithelial barrier dysfunction in endotoxemic mice and immunostimulated Caco-2 enterocytic monolayers. J Pharmacol Exp Ther 304:464-476
24. Sappington PL, Cruz RJ Jr, Harada T et al 2005 The ethyl pyruvate analogues, diethyl oxaloproprionate, 2-acetamidoacrylate, and methyl-2-acetamidoacrylate, exhibit anti-inflammatory properties in vivo and/or in vitro. Biochem Pharmacol 70:1579-1592
25. Schmidt TJ 1999 Toxic activities of sesquiterpene lactones: structural and biochemical aspects. Curr Org Chem 3:577-608
26. Schmidt TJ, Lyss G, Pahl HL, Merfort I 1999 Helenanolide type sesquiterpene lactones. Part 5: the role of glutathione addition under physiological conditions. Bioorg Med Chem 7:2849-2855
27. Sen R, Baltimore D 1986 Inducibility of kappa immunoglobulin enhancer-binding protein NF-kappaB by a posttranslational mechanism. Cell 47:921-928
28. Sileri P, Schena S, Morini S et al 2001 Pyruvate inhibits hepatic ischemia-reperfusion injury in rats. Transplantation 72:27-30
29. Sims CA, Wattanasirichaigoon S, Menconi MJ, Ajami AM, Fink MP 2001 Ringer's ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats. Crit Care Med 29:1513-1518
30. Snow JT, Finley JW, Friedman M 1976 Relative reactivities of sulfhydryl groups with N-acetyl dehydroalanine and N-acetyl dehydroalanine methyl ester. Int J Peptide Protein Res 8:57-64
31. Song M, Kellum JA, Kaldas H, Fink MP 2004 Evidence that glutathione depletion is a mechanism responsible for the anti-inflammatory effects of ethyl pyruvate in cultured LPSstimulated RAW 264.7 cells. J Pharmacol Exp Ther 308:307-316
32. Tawadrous ZS, Delude RL, Fink MP 2002 Resuscitation from hemorrhagic shock with Ringer's ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats. Shock 17:473-477
33. Tsung A, Kaizu T, Nakao A et al 2005 Ethyl pyruvate ameliorates liver ischemia-reperfusion injury by decreasing hepatic necrosis and apoptosis. Transplantation 27:196-204
34. Ulloa L, Ochani M, Yang H et al 2002 Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci USA 99:12351-12356
35. Varma SD, Devamanoharan PS, Ali AH 1998 Prevention of intracellular oxidative stress to lens by pyruvate and its ester. Free Rad Res 28:131-135
36. Venkataraman R, Kellum JA, Song M, Fink MP 2002 Resuscitation with Ringer's ethyl pyruvate solution prolongs survival and modulates plasma cytokine and nitrite/nitrate concentrations in a rat model of lipopolysaccharide-induced shock. Shock 18:507-512
37. Wang H, Bloom O, Zhang M et al 1999 HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251
38. Yang R, Gallo DJ, Baust JJ et al 2002 Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol 283:G212-222
39. Yang H, Wang H, Li J et al 2004 Reversing established sepsis with antagonists of endogenous HMGB1. Proc Natl Acad Sci USA 101:296-301
40. Yu YM, Kim JB, Lee KW, Kim SY, Han PL, Lee JK 2005 Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window. Stroke 36:2238-2243